Sign in

CIK 0001842295 · Non-accelerated filer<br>Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6508505070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 4 Insider Changes in Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 144 Insider Sale of Securities
  5. 10-K Report Annual Report
  6. 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 144 Insider Sale of Securities
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. S-3ASR Offering Registration Statement

Page 5 of 12 · 224 filings